4th Quarter - Report
THE DUBERSTEIN GROUP INC. for PHRMA INC.
Client
Income
$75,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug Pricing Issues related to COVID-19: H.R.133 - Consolidated Appropriations Act, 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| KATHERINE WINKLER KEATING | — |
| DAVID J SCHIAPPA | — |
| ANNE WALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.